ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding ESSA Pharma Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 45 | 36 | −9 |
| Shares | 32.8M | 31.7M | −1.15M (−3.5%) |
| Value | $58.8M | $50.1M | −$8.71M (−14.8%) |
New holders (3)
Institutions that held ESSA Pharma Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DLD Asset Management, LP | 183,658 | $290.2K | 0.04% |
| Deuterium Capital Management, LLC | 110,412 | $174.5K | 0.39% |
| Shay Capital LLC | 24,631 | $38.9K | 0.01% |
Sold out (12)
Institutions that held ESSA Pharma Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| RTW Investments, LP | 1,113,002 | $1.99M |
| Marshall Wace, LLP | 181,217 | $324.4K |
| Vazirani Asset Management LLC | 50,000 | $89.5K |
| Jane Street Group, LLC | 45,810 | $82.0K |
| Prelude Capital Management, LLC | 25,000 | $44.8K |
| FNY Investment Advisers, LLC | 25,000 | $44.0K |
| Susquehanna International Group, LLP | 17,704 | $31.7K |
| GTS Securities LLC | 16,700 | $29.9K |
| Two Sigma Securities, LLC | 15,943 | $28.5K |
| Acadian Asset Management LLC | 15,687 | $28.0K |
| Squarepoint Ops LLC | 14,525 | $26.0K |
| 49 Wealth Management, LLC | 11,172 | $20.0K |